YMRC
ANIP icon

Yorktown Management & Research Company’s ANI Pharmaceuticals ANIP Stock Holding History

Yorktown Management & Research Company’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,050
Closed -$250K – 240
2019
Q4 		$250K Hold
4,050
– – 0.13% 230
2019
Q3 		$295K Buy
+4,050
New +$303K 0.16% 177

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Yorktown Management & Research Company's ANIP Position: Q1 2020 in Review

Yorktown Management & Research Company sold out of ANI Pharmaceuticals (ANIP) in Q1 2020, closing a stake of 4,050 shares — an estimated $250K sold.

Yorktown Management & Research Company first reported a position in ANIP in Q3 2019 and held it in 2 quarters. The position peaked at $295K in Q3 2019. 141 funds tracked by Wall St. Rank hold ANIP as of Q1 2020.

  • Yorktown Management & Research Company reported no remaining ANI Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Yorktown Management & Research Company sold 4,050 ANI Pharmaceuticals shares in Q1 2020, an estimated $250K.
  • Yorktown Management & Research Company first reported a position in ANI Pharmaceuticals in Q3 2019 and held it in 2 quarters.
  • Yorktown Management & Research Company's ANI Pharmaceuticals position peaked at $295K in Q3 2019.
  • 141 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2020.

Based on Yorktown Management & Research Company's 13F filing for Q1 2020, filed 29 Apr 2020.